Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4+CD25+ T cells

被引:207
作者
Suri-Payer, E [1 ]
Cantor, H [1 ]
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
关键词
autoimmune gastritis; regulatory T Cells; CD25; cytokine; colitis;
D O I
10.1006/jaut.2000.0473
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Murine autoimmune gastritis, induced by neonatal thymectomy or the injection of CD25-depleted lymphocytes into nu/nu recipients, is characterized by an inflammatory infiltrate into the gastric mucose, parietal cell destruction and circulating anti-parietal cell antibodies. Using RAG-2(-/-) mice as recipients, we determined that the induction of disease relies on CD4(+)CD25(-) effector cells and prevention relies on CD4(+)CD25(+) regulatory cells; neither requires participation of CD8 cells or B cells. The severity of gastritis was dependent on the cytokine repertoire of CD4(+)CD25(-) effector T cells. Recipients of IL-4(-/-) T cells developed more severe gastritis and recipients of INF-gamma (-/-) T cells developed milder disease than recipients of wildtype or IL-10(-/-) effector T cells. Gastritis did not develop in the absence of IL-12. Protection from gastritis does not require either IL-4 or IL-10 because CD4(+)CD25(+) cells from IL-4(-/-) or IL-10(-/-) mice completely abrogated the disease process. CD4(+)CD25(+) cells also protected RAG-2(-/-) recipients from colitis and inhibitory activity was partially dependent on IL-10 expression. These findings highlight the critical role of CD4(+)CD25(+) regulatory T cells in protection from several autoimmune syndromes and delineate the differential contribution of IL-10 to CD4(+)CD25(+) Treg activity in the settings of gastritis and colitis. (C) 2001 Academic Press.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 55 条
[1]   Regulatory CD4 T cells control the size of the peripheral activated/memory CD4 T cell compartment [J].
Annacker, O ;
Burlen-Defranoux, O ;
Pimenta-Araujo, R ;
Cumano, A ;
Bandeira, A .
JOURNAL OF IMMUNOLOGY, 2000, 164 (07) :3573-3580
[2]   Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation [J].
Asano, M ;
Toda, M ;
Sakaguchi, N ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :387-396
[3]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[4]   Interferon-gamma is required during the initiation of an organ-specific autoimmune disease [J].
Barrett, SP ;
Gleeson, PA ;
deSilva, H ;
Toh, BH ;
vanDriel, IR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (07) :1652-1655
[5]  
Begolka WS, 1998, RES IMMUNOL, V149, P771
[6]   Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses [J].
Berg, DJ ;
Davidson, N ;
Kuhn, R ;
Muller, W ;
Menon, S ;
Holland, G ;
ThompsonSnipes, L ;
Leach, MW ;
Rennick, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (04) :1010-1020
[7]  
Bregenholt S, 1999, CLIN EXP IMMUNOL, V118, P228
[8]  
Cederbom L, 2000, EUR J IMMUNOL, V30, P1538, DOI 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO
[9]  
2-X
[10]   IMMUNOGLOBULIN GENE REARRANGEMENT IN B-CELL DEFICIENT MICE GENERATED BY TARGETED DELETION OF THE J(H) LOCUS [J].
CHEN, JZ ;
TROUNSTINE, M ;
ALT, FW ;
YOUNG, F ;
KURAHARA, C ;
LORING, JF ;
HUSZAR, D .
INTERNATIONAL IMMUNOLOGY, 1993, 5 (06) :647-656